Annelieke Paantjens

Annelieke Paantjens currently serves as the Director of Clinical and Regulatory Writing at Acerta Pharma B.V., focusing on leading the CReW program for haematology since May 2022. Prior to this role, Annelieke held multiple positions at AstraZeneca from March 2015 to May 2022, culminating in the Director of Clinical and Regulatory Writing, where responsibilities included ensuring alignment of clinical documents with project strategies and regulatory requirements. Annelieke's experience also includes senior regulatory affairs roles at Merck, focusing on pharmaceutical CMC and biologics, and a PhD in Immunology from UMC Utrecht, where research concentrated on chronic rejection in lung transplantation. Education credentials include a Master's and Bachelor's in Molecular Sciences from Wageningen University & Research.